Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-11-09 4:37 pm Sale |
2023-11-03 | 13D | LAVA Therapeutics N.V. LVTX |
Novo Holdings A/S | 1,878,194 7.100% |
-521,806 (-21.74%) |
Filing History |
| 2023-08-11 4:40 pm Purchase |
2023-08-09 | 13D | IO Biotech, Inc. IOBT |
Novo Holdings A/S | 8,216,202 12.000% |
4,938,270 (+150.65%) |
Filing History |
| 2023-08-03 5:02 pm Sale |
2023-07-28 | 13D | CYTEIR THERAPEUTICS INC CYTT |
Novo Holdings A/S | 1,547,136 4.400% |
-1,525,000 (-49.64%) |
Filing History |
| 2023-07-26 4:58 pm Sale |
2023-07-20 | 13D | CYTEIR THERAPEUTICS INC CYTT |
Novo Holdings A/S | 3,072,136 8.700% |
-868,277 (-22.04%) |
Filing History |
| 2023-06-28 5:22 pm Sale |
2023-06-28 | 13G | Disc Medicine, Inc. IRON |
Novo Holdings A/S | 1,090,772 4.800% |
-1,250,000 (-53.40%) |
Filing History |
| 2023-06-28 4:19 pm Sale |
2023-06-27 | 13G | Galera Therapeutics, Inc. GRTX |
Novo Holdings A/S | 2,100,000 4.900% |
-359,021 (-14.60%) |
Filing History |
| 2023-06-28 4:17 pm Unchanged |
2023-06-19 | 13D | Edgewise Therapeutics, Inc. EWTX |
Novo Holdings A/S | 6,071,703 9.600% |
0 (Unchanged) |
Filing History |
| 2023-06-05 8:18 pm Sale |
2023-06-05 | 13D | LAVA Therapeutics N.V. LVTX |
Novo Holdings A/S | 2,400,000 9.130% |
-670,558 (-21.84%) |
Filing History |
| 2023-05-26 4:51 pm Sale |
2023-05-25 | 13G | VectivBio Holding AG VECT |
Novo Holdings A/S | 0 0.000% |
-3,339,484 (Position Closed) |
Filing History |
| 2023-05-15 5:16 pm Unchanged |
2023-05-09 | 13D | Reneo Pharmaceuticals, Inc. RPHM |
Novo Holdings A/S | 343,038 10.200% |
0 (Unchanged) |
Filing History |
| 2023-02-24 4:38 pm Sale |
2023-02-22 | 13D | LAVA Therapeutics N.V. LVTX |
Novo Holdings A/S | 3,070,558 11.700% |
-256,754 (-7.72%) |
Filing History |
| 2023-02-21 4:28 pm Purchase |
2023-02-16 | 13D | Spruce Biosciences, Inc. SPRB |
Novo Holdings A/S | 8,378,336 19.900% |
3,864,000 (+85.59%) |
Filing History |
| 2023-02-17 4:32 pm Purchase |
2023-02-08 | 13G | LanzaTech Global, Inc. LNZA |
Novo Holdings A/S | 15,814,845 8.100% |
15,814,845 (New Position) |
Filing History |
| 2023-02-02 1:24 pm Sale |
2022-12-31 | 13G | VectivBio Holding AG VECT |
Novo Holdings A/S | 3,339,484 5.300% |
-182,535 (-5.18%) |
Filing History |
| 2023-02-02 1:24 pm Sale |
2022-12-31 | 13G | Evotec SE EVO |
Novo Holdings A/S | 17,444,807 9.800% |
-450,000 (-2.51%) |
Filing History |
| 2023-01-04 4:20 pm Sale |
2022-12-29 | 13D | Bolt Biotherapeutics, Inc. BOLT |
Novo Holdings A/S | 0 0.000% |
-2,534,465 (Position Closed) |
Filing History |
| 2023-01-03 4:30 pm Purchase |
2022-12-29 | 13G | Disc Medicine, Inc. IRON |
Novo Holdings A/S | 2,340,772 13.800% |
2,340,772 (New Position) |
Filing History |
| 2022-12-28 2:51 pm Sale |
2022-12-21 | 13D | Bolt Biotherapeutics, Inc. BOLT |
Novo Holdings A/S | 2,534,465 6.700% |
-1,169,526 (-31.57%) |
Filing History |
| 2022-12-12 4:26 pm Sale |
2022-12-06 | 13G | Arcellx, Inc. ACLX |
Novo Holdings A/S | 1,750,000 4.000% |
-757,076 (-30.20%) |
Filing History |
| 2022-11-28 1:57 pm Sale |
2022-11-18 | 13G | Arcellx, Inc. ACLX |
Novo Holdings A/S | 2,507,076 5.700% |
-1,509,802 (-37.59%) |
Filing History |